This study is in progress, not accepting new patients

Positive Steps to Enhance Problem Solving Skills

a study on Treatment Adherence HIV/AIDS

Summary

Eligibility
for people ages 16-29 (full criteria)
Healthy Volunteers
healthy people welcome
Location
at UCLA
Dates
study started
completion around
Principal Investigator
by Matthew J Mimiaga, ScD, MPH (ucla)
Headshot of Matthew J Mimiaga
Matthew J Mimiaga

Description

Summary

This randomized control trial is to test the efficacy of a stepped-care "adaptive" Antiretroviral Therapy (ART) adherence intervention ("Positive STEPS") for HIV infected adolescents and young adults, ages 16 to 29. Stepped care is a healthcare delivery model in which the least resource intensive part of an intervention is delivered first, and only those who do not improve then receive the high intensity, more resource intensive part of an intervention.

Official Title

Adaptive Intervention Strategies Trial for Strengthening Adherence to Antiretroviral HIV Treatment Among Youth

Details

HIV infected adolescents and young adults will be recruited from Providence, Rhode Island, Boston, Massachusetts and Chicago, Illinois. Participants will be equally randomized to:

  1. "Positive STEPS" - a stepped care, adherence intervention with integrated technology (2-way daily text messaging aimed at improving ART adherence). If text messaging is not sufficient to overcome the barriers to ART adherence;these individuals will then also receive the more intensive component based on general principles of cognitive-behavioral therapy.
  2. Standard of Care comparison group including a brief adherence educational session. This will consist of a review of medications and recommended dosing (i.e., to understand regimen), adherence expectations, toxicity expectations and medication misperceptions.The participant will then view a 20-minute animated tutorial which explains the importance of adherence to antiretroviral medication effectiveness.

Keywords

Adherence, HIV, ART Adherence, Adolescents, Positive STEPS

Eligibility

You can join if…

Open to people ages 16-29

  • Between 16 and 29 years of age
  • HIV-infected (perinatally, transfusion, or behaviorally-acquired)
  • Currently taking or prescribed antiretroviral therapy and: 1) Began taking ART < 3 months ago, OR 2) Has been taking ART for >3 AND has missed one or more doses in the past week or more than 3 doses in the past month.
  • Daily access to a cell phone
  • Has lived in the greater Providence, Boston, or Chicago area greater than three months
  • Self-reports < 90% ART medication adherence in the past month (i.e., missed one or more doses in the past week or more than 3 doses in the past month) at screening
  • Able to speak and understand English
  • Not currently enrolled in another ART-adherence intervention study
  • Willing and able to complete all study visits in person or remotely via video conferencing platform

You CAN'T join if...

  • Unable to give informed consent due to severe mental or physical illness, cognitive limitation, or substance intoxication at baseline visit
  • HIV-uninfected
  • Not currently on antiretroviral therapy
  • Does not own a cell phone
  • Has lived in the greater Providence, Boston, or Chicago area for less than three months or is planning to move outside the area within the next year
  • Self-reports > 90% ART medication adherence in the past month AND has been taking ART for more than 3 months
  • Unable to speak and understand English
  • Currently enrolled in another ART-adherence intervention study
  • Not willing to and able to complete all study visits in person or remotely via video conferencing platform

Locations

  • UCLA Center for LGBTQ+ Advocacy, Research & Health
    Los Angeles California 90095 United States
  • Lurie Childrens Hospital
    Chicago Illinois 60611 United States
  • Brown University School of Public Health
    Providence Rhode Island 02912 United States
  • Fenway Health Institute
    Boston Massachusetts 02215 United States

Lead Scientist at University of California Health

Details

Status
in progress, not accepting new patients
Start Date
Completion Date
(estimated)
Sponsor
University of California, Los Angeles
ID
NCT03092531
Study Type
Interventional
Participants
Expecting 192 study participants
Last Updated